Developer of a genetic inference technology designed to lead the genomic transformation by finding new drug targets for serious diseases. The company uses an analytical platform for genomic sequence d...

Healthcare
Oxford, United Kingdom
Founded 2014
195 employees
Website
Valuation
$161.6M
Latest known
Share Price
N/A
Total Raised
$142.2M
Last Round
N/A